Radiosensitization of Celecoxib for Glioma Cells
Xiao-Ting Xu
Abstract
Xiao-Ting Xu
Abstract
Purpose To study the radiosensitization of celecoxib to three strains of glioma cells. Methods Celecoxib with proper concentration was adapted for radiosensitive experiments for SHG-44 cells,767 cells and C6 cells. The cells were randomized into two groups,radiation alone group (R),and radiation combined with celecoxib group (R+D). Celecoxib’s radiosensitization was measured by clongenic assay,and survival curve was described. Result Celecoxib displayed radiosensitizing effect in the three strains of glioma cells. The Value of D0,Dq,SF2 and D0.01 of group R+D was significantly lower than that of group R (tSF2=83.5,P=0.014;tD0.01=9.28,P=0.011;tD0=3.985,P=0.058;tDq=3.348,P=0.075). Conclusion The COX-2 selected inhibitor,celecoxib could enhance radiation effect in three strains of glioma cells in vitro. Celecoxib might become an effected radiosensitizer in the treatment for glioma.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Purpose To study the radiosensitization of celecoxib to three strains of glioma cells. Methods Celecoxib with proper concentration was adapted for radiosensitive experiments for SHG-44 cells,767 cells and C6 cells. The cells were randomized into two groups,radiation alone group (R),and radiation combined with celecoxib group (R+D). Celecoxib’s radiosensitization was measured by clongenic assay,and survival curve was described. Result Celecoxib displayed radiosensitizing effect in the three strains of glioma cells. The Value of D0,Dq,SF2 and D0.01 of group R+D was significantly lower than that of group R (tSF2=83.5,P=0.014;tD0.01=9.28,P=0.011;tD0=3.985,P=0.058;tDq=3.348,P=0.075). Conclusion The COX-2 selected inhibitor,celecoxib could enhance radiation effect in three strains of glioma cells in vitro. Celecoxib might become an effected radiosensitizer in the treatment for glioma.
Key concepts: Celecoxib, Radiosensitizer, Medicine, Glioma, In vitro, Pharmacology, Cancer research, Radiation therapy